Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1979 Sep;37(3):495-501.

Receptors for IgM on human lymphocytes. III. Specificity of receptors

Receptors for IgM on human lymphocytes. III. Specificity of receptors

M W Fanger et al. Clin Exp Immunol. 1979 Sep.

Abstract

Receptors for the Fc portion of IgM (RFcmu) can be detected on a large percentage of human peripheral lymphocytes. To approach an understanding of the function of these receptors we have examined the relative efficiencies of different preparations of human IgM and their F(c)5 mu fragments in binding to RFcmu. This was measured by blocking rosette formation between lymphocytes and IgM-sensitized ox erythrocytes (EAmu). IgM from pooled normal human serum completed blocked formation of IgM rosettes (EAmu-RFC) at much lower concentrations than IgM preparations from individual Waldenström's macroglobulinaemic patients (WM). The differences in effectiveness of these IgM preparations in inhibiting EAmu-RFC suggested the existence of receptors for subclasses of IgM on different subpopulations of human lymphocytes. F(c)5 mu fragments of IgM were more effective in blocking EAmu-RFC than the parent molecule, which was in turn more efficient than the 8S subunit. These results indicate that F(c)5 mu may have more Fc regions exposed per molecule for binding to the matrix of RFcmu than pentameric IgM and that Fc multivalency may be important for the stable binding of IgM to RFcmu.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Immunology. 1978 Mar;34(3):449-58 - PubMed
    1. Nature. 1977 Jan 13;265(5590):160-1 - PubMed
    1. Scand J Immunol. 1977;6(9):873-8 - PubMed
    1. J Immunol. 1978 Jul;121(1):1-5 - PubMed
    1. J Immunol. 1977 Dec;119(6):2206-8 - PubMed

LinkOut - more resources